KEC Intl PAT grows marginally in Q4FY19
KEC Intl PAT grows marginally in Q4FY19

KEC Intl PAT grows marginally in Q4FY19

Apurva Joshi Article rating: 5.0

KEC International reported its results for the quarter ended March 31, 2019 on Wednesday after market hours. The company's consolidated revenue for Q4FY19 came in at Rs. 3,841.17 crore as against Rs. 3,662.37 crore in the corresponding quarter last year, registering 4.9 per cent yoy increase.

Overnight Digest: Stocks to look out for on May 9
Overnight Digest: Stocks to look out for on May 9

Overnight Digest: Stocks to look out for on May 9

Shohini Nath Article rating: 3.6

The stocks that are likely to witness significant movement on the bourses on May 9 are Lupin, Dilip Buildcon, Voltas, Eros International and UPL.


Market Close: Sensex, Nifty sink further
Market Close: Sensex, Nifty sink further

Market Close: Sensex, Nifty sink further

Gayathri Udyawar Article rating: 4.3

Market on Wednesday opened in the green but soon after the pre-opening session slipped in the red zone. Market trade around the 38,000 level for the most part of the first half of the day and then lost more ground in the afternoon session to close down by 487 points or 1.27 per cent. The biggest draggers were Tata Motors and Reliance.


Jet Airways gets wooed by new entrepreneurs
Jet Airways gets wooed by new entrepreneurs

Jet Airways gets wooed by new entrepreneurs

Gayathri Udyawar Article rating: 5.0

The latest investors for the debt-ridden airline were a British airline, a non-resident Indian and investment firms Adi Partners, Future Trend Capital and Radcliffe Capital.

NBCC secures order worth Rs. 362 crore in April
NBCC secures order worth Rs. 362 crore in April

NBCC secures order worth Rs. 362 crore in April

Amir Shaikh Article rating: 5.0

NBCC (India) has secured a total business of Rs. 361.91 crore in the month of April 2019. Earlier, the company had secured a total business of Rs. 3,031.70 crore in March 2019.

Indoco Remedies: New Baddi facility receives UK-MHRA approval
Indoco Remedies: New Baddi facility receives UK-MHRA approval

Indoco Remedies: New Baddi facility receives UK-MHRA approval

Advait Dharmadhikari Article rating: 4.8

Indoco Remedies announced that it received approval from the UK-MHRA (Medicines and Healthcare Products Regulatory Agency) for its new solid dosages manufacturing facility in Baddi, Himachal Pradesh (Baddi III unit). The inspection was held from October 16 to 18, 2018.

Top 5 mid cap winners and losers in April
Top 5 mid cap winners and losers in April

Top 5 mid cap winners and losers in April

Apurva Joshi Article rating: 5.0

We have found some mid-cap stocks that outperformed and underperformed in the month of April as compared to the mid-cap index. Read on to find out more....


Ratnamani Metals secures new order worth Rs. 255 crore
Ratnamani Metals secures new order worth Rs. 255 crore

Ratnamani Metals secures new order worth Rs. 255 crore

Pratik Shastri Article rating: 4.7

Gujarat-based pipes and tubes manufacturer, Ratnamani Metals & Tubes Limited informed in the exchange through a filing that the company has secured a new order for CS coated pipes.

Natco gets USFDA nod for Nitroglycerin sublingual tablets
Natco gets USFDA nod for Nitroglycerin sublingual tablets

Natco gets USFDA nod for Nitroglycerin sublingual tablets

Apurva Joshi Article rating: 5.0

Natco Pharma’s marketing partner Alvogen has received final approval of Abbreviated New Drug Application (ANDA) from USFDA for Nitroglycerin Sublingual Tablets USP, 0.3 mg, 0.4 mg, and 0.6 mg.

RSS
First26912692269326942696269826992700Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR